CSL Behring - About the company
CSL Behring is a funded company based in King Of Prussia (United States), founded in 2009. It operates as a Developer of therapeutic solutions for the treatment of coagulation disorder. CSL Behring has raised an undisclosed amount in funding.
Company Details
CSL Behring is focused on the development, manufacture, and marketing of protein-based therapies for serious and chronic medical conditions. The company offers products in the area of Bleeding Disorders Therapies, Fluid Replacement Therapies, Hereditary Angioedema (HAE) Therapies, Immunoglobulin Therapies, Pulmonary Therapies, and Wound Healing Therapies. The products are used for the treatment of coagulation disorders including von Willebrand disease (VWD), hemophilia, primary immunodeficiency (PID), hereditary Angioedema (HAE), fibrinogen deficiency, genetic emphysema, and other rare diseases.
- Website
- cslbehring.com
- Social
Key Metrics
Founded Year
2009
Location
King Of Prussia, United States
Stage
Funding Raised
Latest Funding Round
Investors
Employee Count
5,000 - 9,999 as on Mar 01, 2026
Sign up to download CSL Behring's company profile
CSL Behring's funding and investors
CSL Behring has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jun 17, 2020 for $*****. 1 investor participated in its latest round. CSL Behring has 1 institutional investor.
Here is the list of recent funding rounds of CSL Behring:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 17, 2020 | 4520473 | Grant (prize money) | 2486060 | 3635627 | 8976138 | 3538736 |
Access funding benchmarks and valuations. Sign up today!View details of CSL Behring's funding rounds and investors
CSL Behring's founders and board of directors
Founder? Claim ProfileCSL Behring's employee count trend
CSL Behring has 5,000 - 9,999 employees as of Mar 26. Here is CSL Behring's employee count trend over the years:
Uncover CSL Behring's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
CSL Behring's Investments and acquisitions
CSL Behring has acquired 2 companies including Vitaeris and Calimmune. CSL Behring has not made any investments as of now.Reports related to CSL Behring
Here is the latest report on CSL Behring's sector:
News related to CSL Behring
Filter this listMedia has covered CSL Behring for 1 event in last 1 year, It was about company updates.
•
CSL Breaks Ground on $1.5B Illinois Immunoglobulin Plant ExpansionConstruction Dive•Mar 11, 2026•CSL Behring
•
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private EquityMedCity News•Feb 22, 2025•Bluebird Bio, The Carlyle Group, SK Capital, Pfizer and 8 others
•
uniQure Announces Sale of Royalty Interest in HEMGENIX® for Up To $400 MillionGlobeNewswire•May 15, 2023•UniQure, HEMGENIX, CSL Behring, HCRx and 1 other
•
•
•
•
•
CSL, uniQure gene therapy granted FDA approval for hemophilia BSeeking Alpha•Nov 23, 2022•CSL, UniQure, Carlisle, CSL Behring
•
The FDA just approved the world’s most expensive drug — $3.5 million a doseFinancial Post•Nov 23, 2022•CSL Behring
•
BrightInsight Inks Enterprise Agreement with CSL Behring for Digital Health Solutions Across Brand PortfolioGlobeNewswire•Nov 14, 2022•BrightInsight, CSL Behring
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about CSL Behring
Explore our recently published companies
- Lacy And Par - Tukwila based, 1984 founded, Unfunded company
- Moeheat - Santa Clarita based, 2008 founded, Public company
- Z-axis Prints - Spokane based, 2010 founded, Unfunded company
- Zen Creative Group - Portland based, 1995 founded, Unfunded company
- Rjo Ventures - North Miami Beach based, 2011 founded, Unfunded company
- Roberts Design - Las Vegas based, 2014 founded, Unfunded company
